PULMONARY SARCOIDOSIS

Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new PULMONARY SARCOIDOSIS trials appear

Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental drug aims to improve breathing in lung sarcoidosis

Disease control Not yet recruiting

This study tests an investigational drug called XTMAB-16 in people with pulmonary sarcoidosis, a condition that causes inflammation and scarring in the lungs. The trial aims to see if the drug can improve lung function (measured by forced vital capacity) and quality of life. Part…

Matched conditions: PULMONARY SARCOIDOSIS

Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control

Last updated Jul 03, 2026 20:42 UTC

PULMONARY SARCOIDOSIS

Get alerted when new PULMONARY SARCOIDOSIS trials appear

Experimental drug aims to improve breathing in lung sarcoidosis